BDMS Dominates with 1Q Earnings: Bangkok Dusit Medical Services Surpasses Predictions

Bangkok Dusit Medical Services on Smartkarma

Analyst coverage on Bangkok Dusit Medical Services by Tina Banerjee on Smartkarma highlights positive growth trends in the company’s core business. According to the report, BDMS experienced double-digit growth in the fourth quarter of 2023, driven by both international and Thai non-COVID patient revenues. The company expects this growth momentum to continue in 2024, supported by favorable conditions in the Thai healthcare sector. In 2023, BDMS achieved total revenue of THB102 billion, a 10% year-over-year increase, surpassing the higher end of the guidance range. The EBITDA margin also remained strong at 24.2%, exceeding the expected 24.0%.

In a separate report, Tina Banerjee on Smartkarma notes that Bangkok Dusit Medical Services achieved its highest ever quarterly sales in the third quarter of 2023. The 11% year-over-year revenue growth was fueled by strong performance from international and Thai patients. Notably, international patient revenues saw significant increases from key markets like Qatar, China, and Cambodia. As a result of this robust performance, BDMS raised its 2023 hospital revenue growth guidance to 9–10% year-over-year. Despite this positive outlook, the EBITDA margin guidance remains steady at around 24%, indicating a balance between growth and profitability for the company.

A look at Bangkok Dusit Medical Services Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

In assessing the long-term outlook for Bangkok Dusit Medical Services Public Company Limited, the Smartkarma Smart Scores provide valuable insights. With a strong score of 4 in both Growth and Resilience, the company appears well-positioned for future expansion and exhibits robustness in the face of challenges. Additionally, Bangkok Dusit Medical Services scores a solid 3 in Dividend, indicating a moderate but stable dividend outlook. Momentum, standing at 4, suggests that the company is showing positive upward trends in performance, potentially indicating further growth in the future.

Bangkok Dusit Medical Services operates Bangkok General Hospital with a focus on various specialized medical services, including cardiovascular, lung, and neurological treatments. The hospital also offers services related to eye and genitourinary cancer, along with physical therapy and medical imaging. Overall, with its promising scores in Growth, Resilience, Dividend, and Momentum, Bangkok Dusit Medical Services appears to be a company with a positive long-term outlook within the medical services industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma